News
-
Psychedelic News, November 2026: Ballots, the FDA and Ibogaine Funding
Idaho's HJR 4 fails, three Oregon towns keep psilocybin bans, Compass files its psilocybin NDA, and HHS funds ibogaine groundwork. Dated facts, no hype.
-
The FDA Just Fast-Tracked Three Psychedelics — Here's What Actually Changed
In late April 2026 the FDA issued National Priority Vouchers to three psychedelic programs — Compass Pathways’ COMP360, Usona Institute’s psilocybin, and Transcend Therapeutics’ methylone — after a Trump executive...